Leadership Team

Dr. Bezwada earned his Ph.D. in Chemistry from the Stevens Institute of Technology in New Jersey. His career spans more than 40 years, including 20 years at Ethicon, Inc. (a Johnson & Johnson Company), where he pioneered numerous life-changing technologies. His research contributions were instrumental in the development of Monocryl_®, an ultra-pliable synthetic absorbable monofilament suture that revolutionized wound closure due to its strength, flexibility, and rapid absorption characteristics. Monocryl_® is widely used in various surgical procedures, including soft tissue repair and gynecological and obstetric surgeries. Since its launch in 1993, Monocryl_® has generated over $2 billion in sales and continues to achieve annual sales of more than $100 million. In recognition of his contributions, Dr. Bezwada was awarded the prestigious Johnson Medal by Johnson & Johnson in 1996.

Building on his extensive experience, Dr. Bezwada founded Bezwada Biomedical in 2003 to continue his work in biodegradable medical technologies. Dr. Bezwada is a prolific inventor, holding more than 152 issued U.S. patents, with a focus on absorbable polyurethanes, amino acid polymers, polyester amides, and polyoxaesters. His contributions have led to the development of FDA-approved products, including the MONTAGE_® family of products, a bone hemostat utilizing his absorbable polyurethane technology. This product, developed and commercialized by Abyrx Inc., is widely used in wound healing and bone applications, offering significant benefits such as enhanced hemostasis and improved tissue compatibility. By utilizing Bezwada’s absorbable polyurethane technology, MONTAGE_® provides a safe, effective, and biologically compatible option for surgical procedures that require quick and reliable blood clotting and tissue stabilization.

In addition to his entrepreneurial achievements, Dr. Bezwada’s contributions to the scientific community are extensive. He has authored numerous scholarly articles and presented his work at prestigious international conferences, including those hosted by the American Chemical Society and the Society for Biomaterials. His work continues to shape the future of biodegradable medical technologies, with his recent achievements including securing an NSF Phase 1 SBIR grant in 2020 for the development of absorbable polyurethane tissue adhesives, followed by an NSF Phase 2 SBIR grant in 2023 to further TissuBond™ product commercialization.

Beyond his technical achievements, Dr. Bezwada is deeply committed to philanthropy. He founded the Society for Basic Needs in India, a non-profit organization focused on improving the lives of underserved communities by providing access to essential health services, education, and basic amenities. Dr. Bezwada also offers scholarships to meritorious students to help them complete high school. He organizes eye health camps, helps college students with tuition fees, and supports food programs to ensure students’ well-being.

Through his unwavering commitment to scientific progress, impactful contributions to medical science, and dedicated efforts to improve the lives of others, Dr. Bezwada continues to make a profound and lasting difference in the medical device industry and beyond.

Dr. Neeti Srivastava has been a key member of Bezwada Biomedical since 2009, bringing over 15 years of experience in biomedical research and a Ph.D. in Biochemistry. With deep expertise in absorbable polymers, drug delivery systems, biomaterials, and quality management systems, Dr. Srivastava leads research and development, business development, and quality assurance, always focusing on creating innovative, safe, and effective solutions to improve patient care.

Dr. Srivastava has extensive knowledge of Bezwada’s absorbable polyurethane technology, including bio-based polyurethanes, and holds patents on the technology, solidifying her position as a leader in polymer science. Her contributions were essential in the creation of TissuBond™, a tissue adhesive that secured NSF SBIR Phase I and II grants. She also worked on absorbable polyurethane formulations for a bone hemostat product that received 510(k) approval from the FDA and was commercialized as MONTAGE_® by Abyrx, Inc.

Her leadership and dedicated efforts were instrumental in Bezwada Biomedical’s achievement of ISO 9001 and ISO 13485 certifications. Through her guidance in building a robust quality management system, she has ensured the company’s commitment to delivering safe and effective polymers that meet the highest regulatory standards.

Dr. Srivastava is also an established voice in the scientific community, having authored multiple scholarly articles and presented her research at esteemed conferences such as the American Chemical Society and the Society for Biomaterials. Her work continues to drive both academic and industrial advancements in biomedical science and drug delivery technologies.

Ms. Sujata Moton oversees all financial matters at Bezwada Biomedical including accounting, budgeting, and taxation functions and has all human resources responsibilities.
Ms. Moton holds a Bachelor’s degree in accounting and an MBA in finance, both from Rutgers University. Her experience also includes management and accounting positions with Johnson & Johnson.

Ms. Sujata Moton oversees all financial matters at Bezwada Biomedical including accounting, budgeting, and taxation functions and has all human resources responsibilities.
Ms. Moton holds a Bachelor’s degree in accounting and an MBA in finance, both from Rutgers University. Her experience also includes management and accounting positions with Johnson & Johnson.